Decreased Levels of VAMP2 and Monomeric Alpha-Synuclein Correlate with Duration of Dementia

Julie Vallortigara, David Whitfield, William Quelch, Amani Alghamdi, David Howlett, T. Hortobágyi, Mary Johnson, Johannes Attems, John T. O'Brien, Alan Thomas, Clive G. Ballard, Dag Aarsland, Paul T. Francis

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Alpha-synuclein (β-syn) aggregations are the key pathological hallmark of dementia with Lewy bodies (DLB) and Parkinson's disease dementia (PDD), but are also frequently present in Alzheimer's disease (AD). Much remains unknown about the role of β-syn in the synapse and the wider role of synaptic dysfunction in these dementias. Changes in concentrations of key 'SNAP (Soluble N-ethylmaleimide Sensitive Factor Attachment Protein) Receptor' (SNARE) proteins as a consequence of alterations in the aggregation state of β-syn may contribute to synaptic dysfunction in patients with DLB, PDD, and AD and result in impaired cognition.We have studied a large cohort (n = 130) of autopsy confirmed DLB, PDD, AD, and control brains. Using semi-quantitative western blotting, we have demonstrated significant changes across the diagnostic groups of DLB, PDD, and AD in the SNARE and vesicle proteins syntaxin, Munc18, VAMP2, and monomeric β-syn in the prefrontal cortex, with a significant reduction of Munc18 in AD patients (p <0.001). This correlated to the final MMSE score before death (p = 0.016). We also identified a significant negative correlation between the duration of dementia and the levels of the binding partners VAMP2 (p = 0.0004) and monomeric β-syn (p = 0.0002). Our findings may indicate that an upregulation of SNARE complex related proteins occurs in the early stages of disease as an attempt at compensating for failing synapses, prior to widespread deposition of pathological β-syn.

Original languageEnglish
Pages (from-to)101-110
Number of pages10
JournalJournal of Alzheimer's Disease
Volume50
Issue number1
DOIs
Publication statusPublished - Nov 30 2015

Fingerprint

Vesicle-Associated Membrane Protein 2
alpha-Synuclein
Dementia
Alzheimer Disease
SNARE Proteins
Parkinson Disease
Synapses
Munc18 Proteins
Qa-SNARE Proteins
Prefrontal Cortex
Cognition
Autopsy
Proteins
Up-Regulation

Keywords

  • Alpha-synuclein
  • Alzheimer's disease
  • dementia with lewy bodies
  • munc18
  • Parkinson's disease dementia
  • SNARE process
  • synaptic dysfunction
  • VAMP2

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Geriatrics and Gerontology
  • Clinical Psychology

Cite this

Vallortigara, J., Whitfield, D., Quelch, W., Alghamdi, A., Howlett, D., Hortobágyi, T., ... Francis, P. T. (2015). Decreased Levels of VAMP2 and Monomeric Alpha-Synuclein Correlate with Duration of Dementia. Journal of Alzheimer's Disease, 50(1), 101-110. https://doi.org/10.3233/JAD-150707

Decreased Levels of VAMP2 and Monomeric Alpha-Synuclein Correlate with Duration of Dementia. / Vallortigara, Julie; Whitfield, David; Quelch, William; Alghamdi, Amani; Howlett, David; Hortobágyi, T.; Johnson, Mary; Attems, Johannes; O'Brien, John T.; Thomas, Alan; Ballard, Clive G.; Aarsland, Dag; Francis, Paul T.

In: Journal of Alzheimer's Disease, Vol. 50, No. 1, 30.11.2015, p. 101-110.

Research output: Contribution to journalArticle

Vallortigara, J, Whitfield, D, Quelch, W, Alghamdi, A, Howlett, D, Hortobágyi, T, Johnson, M, Attems, J, O'Brien, JT, Thomas, A, Ballard, CG, Aarsland, D & Francis, PT 2015, 'Decreased Levels of VAMP2 and Monomeric Alpha-Synuclein Correlate with Duration of Dementia', Journal of Alzheimer's Disease, vol. 50, no. 1, pp. 101-110. https://doi.org/10.3233/JAD-150707
Vallortigara, Julie ; Whitfield, David ; Quelch, William ; Alghamdi, Amani ; Howlett, David ; Hortobágyi, T. ; Johnson, Mary ; Attems, Johannes ; O'Brien, John T. ; Thomas, Alan ; Ballard, Clive G. ; Aarsland, Dag ; Francis, Paul T. / Decreased Levels of VAMP2 and Monomeric Alpha-Synuclein Correlate with Duration of Dementia. In: Journal of Alzheimer's Disease. 2015 ; Vol. 50, No. 1. pp. 101-110.
@article{707374c31448472e8867b81fa3f7054f,
title = "Decreased Levels of VAMP2 and Monomeric Alpha-Synuclein Correlate with Duration of Dementia",
abstract = "Alpha-synuclein (β-syn) aggregations are the key pathological hallmark of dementia with Lewy bodies (DLB) and Parkinson's disease dementia (PDD), but are also frequently present in Alzheimer's disease (AD). Much remains unknown about the role of β-syn in the synapse and the wider role of synaptic dysfunction in these dementias. Changes in concentrations of key 'SNAP (Soluble N-ethylmaleimide Sensitive Factor Attachment Protein) Receptor' (SNARE) proteins as a consequence of alterations in the aggregation state of β-syn may contribute to synaptic dysfunction in patients with DLB, PDD, and AD and result in impaired cognition.We have studied a large cohort (n = 130) of autopsy confirmed DLB, PDD, AD, and control brains. Using semi-quantitative western blotting, we have demonstrated significant changes across the diagnostic groups of DLB, PDD, and AD in the SNARE and vesicle proteins syntaxin, Munc18, VAMP2, and monomeric β-syn in the prefrontal cortex, with a significant reduction of Munc18 in AD patients (p <0.001). This correlated to the final MMSE score before death (p = 0.016). We also identified a significant negative correlation between the duration of dementia and the levels of the binding partners VAMP2 (p = 0.0004) and monomeric β-syn (p = 0.0002). Our findings may indicate that an upregulation of SNARE complex related proteins occurs in the early stages of disease as an attempt at compensating for failing synapses, prior to widespread deposition of pathological β-syn.",
keywords = "Alpha-synuclein, Alzheimer's disease, dementia with lewy bodies, munc18, Parkinson's disease dementia, SNARE process, synaptic dysfunction, VAMP2",
author = "Julie Vallortigara and David Whitfield and William Quelch and Amani Alghamdi and David Howlett and T. Hortob{\'a}gyi and Mary Johnson and Johannes Attems and O'Brien, {John T.} and Alan Thomas and Ballard, {Clive G.} and Dag Aarsland and Francis, {Paul T.}",
year = "2015",
month = "11",
day = "30",
doi = "10.3233/JAD-150707",
language = "English",
volume = "50",
pages = "101--110",
journal = "Journal of Alzheimer's Disease",
issn = "1387-2877",
publisher = "IOS Press",
number = "1",

}

TY - JOUR

T1 - Decreased Levels of VAMP2 and Monomeric Alpha-Synuclein Correlate with Duration of Dementia

AU - Vallortigara, Julie

AU - Whitfield, David

AU - Quelch, William

AU - Alghamdi, Amani

AU - Howlett, David

AU - Hortobágyi, T.

AU - Johnson, Mary

AU - Attems, Johannes

AU - O'Brien, John T.

AU - Thomas, Alan

AU - Ballard, Clive G.

AU - Aarsland, Dag

AU - Francis, Paul T.

PY - 2015/11/30

Y1 - 2015/11/30

N2 - Alpha-synuclein (β-syn) aggregations are the key pathological hallmark of dementia with Lewy bodies (DLB) and Parkinson's disease dementia (PDD), but are also frequently present in Alzheimer's disease (AD). Much remains unknown about the role of β-syn in the synapse and the wider role of synaptic dysfunction in these dementias. Changes in concentrations of key 'SNAP (Soluble N-ethylmaleimide Sensitive Factor Attachment Protein) Receptor' (SNARE) proteins as a consequence of alterations in the aggregation state of β-syn may contribute to synaptic dysfunction in patients with DLB, PDD, and AD and result in impaired cognition.We have studied a large cohort (n = 130) of autopsy confirmed DLB, PDD, AD, and control brains. Using semi-quantitative western blotting, we have demonstrated significant changes across the diagnostic groups of DLB, PDD, and AD in the SNARE and vesicle proteins syntaxin, Munc18, VAMP2, and monomeric β-syn in the prefrontal cortex, with a significant reduction of Munc18 in AD patients (p <0.001). This correlated to the final MMSE score before death (p = 0.016). We also identified a significant negative correlation between the duration of dementia and the levels of the binding partners VAMP2 (p = 0.0004) and monomeric β-syn (p = 0.0002). Our findings may indicate that an upregulation of SNARE complex related proteins occurs in the early stages of disease as an attempt at compensating for failing synapses, prior to widespread deposition of pathological β-syn.

AB - Alpha-synuclein (β-syn) aggregations are the key pathological hallmark of dementia with Lewy bodies (DLB) and Parkinson's disease dementia (PDD), but are also frequently present in Alzheimer's disease (AD). Much remains unknown about the role of β-syn in the synapse and the wider role of synaptic dysfunction in these dementias. Changes in concentrations of key 'SNAP (Soluble N-ethylmaleimide Sensitive Factor Attachment Protein) Receptor' (SNARE) proteins as a consequence of alterations in the aggregation state of β-syn may contribute to synaptic dysfunction in patients with DLB, PDD, and AD and result in impaired cognition.We have studied a large cohort (n = 130) of autopsy confirmed DLB, PDD, AD, and control brains. Using semi-quantitative western blotting, we have demonstrated significant changes across the diagnostic groups of DLB, PDD, and AD in the SNARE and vesicle proteins syntaxin, Munc18, VAMP2, and monomeric β-syn in the prefrontal cortex, with a significant reduction of Munc18 in AD patients (p <0.001). This correlated to the final MMSE score before death (p = 0.016). We also identified a significant negative correlation between the duration of dementia and the levels of the binding partners VAMP2 (p = 0.0004) and monomeric β-syn (p = 0.0002). Our findings may indicate that an upregulation of SNARE complex related proteins occurs in the early stages of disease as an attempt at compensating for failing synapses, prior to widespread deposition of pathological β-syn.

KW - Alpha-synuclein

KW - Alzheimer's disease

KW - dementia with lewy bodies

KW - munc18

KW - Parkinson's disease dementia

KW - SNARE process

KW - synaptic dysfunction

KW - VAMP2

UR - http://www.scopus.com/inward/record.url?scp=84954098113&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84954098113&partnerID=8YFLogxK

U2 - 10.3233/JAD-150707

DO - 10.3233/JAD-150707

M3 - Article

C2 - 26639969

AN - SCOPUS:84954098113

VL - 50

SP - 101

EP - 110

JO - Journal of Alzheimer's Disease

JF - Journal of Alzheimer's Disease

SN - 1387-2877

IS - 1

ER -